Reply: Pirtobrutinib: A New and Distinctive Treatment Option for B-Cell Malignancies

AstraZeneca Pharmaceuticals LP. Calquence (Acalabrutinib capsule) [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2022.

AstraZeneca Pharmaceuticals LP. Calquence (Acalabrutinib tablet) [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2022.

Shringi Sharma Pepin Xavier Burri Harini , et al. New acalabrutinib formulation enables co-administration with proton pump inhibitors and dosing in patients unable to swallow capsules (ELEVATE-PLUS). Blood. 2021;138(suppl 1):4365. doi:10.1182/blood-2021-146610.

Janssen Biotech, Inc. and Pharmacyclics LLC. Imbruvica (Ibrutinib capsules, ibrutinib tablets, ibrutinib oral suspension) [package insert]. Janssen Biotech, Inc. and Pharmacyclics LLC; 2024.

BeiGene. Covid-19 infection and pulmonary distress treatment with zanubrutinib in hospitalized participants. NCT04382586. Accessed April 17, 2024. https://clinicaltrials.gov/ct2/show/study/NCG04382586.

Therapeutic Goods Administration. Australian Public Assessment Report for Zanubrutinib- Waldenstrom Macroglobulinemia. Accessed June 3, 2024. www.tga.gov.au/sites/default/files/2022-08/auspar-brukinsa-220811-02.pdf.